Cytek Biosciences Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Cytek Biosciences stock have an average target of 5.88, with a low estimate of 3.00 and a high estimate of 7.50. The average target predicts an increase of 17.84% from the current stock price of 4.99.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$3.00	$5.88	$7.00	$7.50
Change	-39.88%	+17.84%	+40.28%	+50.30%

Analyst Ratings

The average analyst rating for Cytek Biosciences stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	0	0	0	0	0	0
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $8 → $7.5	Buy	Maintains	$8 → $7.5	+50.30%	Nov 11, 2025
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Maintains $9 → $7	Hold	Maintains	$9 → $7	+40.28%	May 28, 2025
Matthew Sykes Goldman Sachs	Goldman Sachs	Strong Sell Maintains $3.5 → $3	Strong Sell	Maintains	$3.5 → $3	-39.88%	May 12, 2025
Mason Carrico Stephens & Co.	Stephens & Co.	Buy Reiterates $6	Buy	Reiterates	$6	+20.24%	Mar 19, 2025
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $8.5 → $8	Buy	Maintains	$8.5 → $8	+60.32%	Mar 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

200.25M

from 200.45M

-0.10%

from 200.45M

Revenue Next Year

211.51M

from 200.25M

5.62%

from 200.25M

EPS This Year

-0.22

from -0.05

EPS Next Year

-0.22

from -0.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	92.84M	127.95M	164.04M	193.02M	200.45M	200.25M	211.51M
Revenue Growth	60.39%	37.82%	28.20%	17.67%	3.85%	-0.10%	5.62%
EPS	0.10	0.00	0.02	-0.09	-0.05	-0.22	-0.22
EPS Growth	-	-99.36%	2,906.28%	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	206.5M	222.4M
Avg	200.3M	211.5M
Low	192.1M	199.2M

Revenue Growth

Revenue Growth	2025	2026
High	3.0%	11.1%
Avg	-0.1%	5.6%
Low	-4.2%	-0.5%

EPS Forecast

EPS	2025	2026
High	-0.20	-0.19
Avg	-0.22	-0.22
Low	-0.23	-0.25

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.